Dr. Eleni Tholouli completed her haematology training in Manchester, undertook a PhD at Manchester University investigating prognostic molecular markers in AML and consolidated her transplant experience
at the Fred Hutchinson Cancer Centre, Seattle-USA, one of the world’s largest transplant centres. Her expertise covers a wide range of haemato-oncological malignancies (leukaemia, myeloma, lymphoma) and non-malignant disorders (bone marrow failures, aplastic anaemia). She is the Director of the Adult Stem Cell and Cellular Therapy Unit. She is a member of the AML working party and steering group, and has authored many publications (manuscripts, book chapters) and presented at scientific congresses.
Dr. Eleni Tholouli completed her haematology training in Manchester, undertook a PhD at Manchester University investigating prognostic molecular markers in AML and consolidated her transplant experience
at the Fred Hutchinson Cancer Centre, Seattle-USA, one of the world’s largest transplant centres. Her expertise covers a wide range of haemato-oncological malignancies (leukaemia, myeloma, lymphoma) and non-malignant disorders (bone marrow failures, aplastic anaemia). She is the Director of the Adult Stem Cell and Cellular Therapy Unit. She is a member of the AML working party and steering group, and has authored many publications (manuscripts, book chapters) and presented at scientific congresses.